When was Valentis founded?
Valentis was founded in 1992.
Where is Valentis's headquarters?
Valentis's headquarters is located at 533 Airport Boulevard, Burlingame.
What is Valentis's latest funding round?
Valentis's latest funding round is PIPE - IV.
Who are the investors of Valentis?
Investors of Valentis include TZP Group, Summer Street Capital Partners and Brantley Partners.
Who are Valentis's competitors?
Competitors of Valentis include Soleno Therapeutics, Vitae Pharmaceuticals, BioCardia, Creative Biomolecules, Advanced Biohealing and 11 more.
You May Also Like
Ribozyme Pharmaceuticals offers RNA-based pharmaceuticals for human disease
Aderis Pharmaceuticals, formerly Discovery Therapeutics, develops and commercializes small molecule, receptor-specific therapeutics for the treatment of central nervous system, cardiovascular and renal diseases.
Neuronyx is focused on developing biomedicines by harnessing the therapeutic potential of the human cell.
Humanetics Corporation is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and wellbeing in markets with urgent and unmet needs with a focus on radiation modulators for oncology, medical imaging and medical countermeasure uses.
Immunomic Therapeutics operates as a development-stage biotechnology company. The Company develops lysosomal associated membrane protein-based vaccines for the treatment of allergy and other human health targets.
Medicorp Technologies Ltd. (now merged into Matrix Laboratories) is a manufacturer of bulk drugs, including the popular Acyclovir. It also manufactures anti-viral, anti-fungal, anti-ulcer and cardiac drugs. Medicorp's core competency lies in the anti-infective, central nervous system and cardiovascular therapeutic segments. Sensing synergies between Matrix Laboratories and Medicorp in the manufacture of bulk drugs, Medicorp merged into Matrix labs.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.